Official Representative of the International Research ofthe Mission for European and International Relation and Cooperation (MREIC) ofthe French National Health Insurance Fund (CNAMTS)
Long term goals and program to achieve the goals. SNOMED CT National Release Center organisation, processes and resources within Socialstyrelsen. Ongoing implementation initiatives.
Lotti Barlow, Socialstyrelsen
SNOMED CT 2019 -seminaari (28.3.2019)
Setting up of new pharmacovigilance centresPriti Gupta
this is just an overview of the setting up of pharamcovigilance with fake name of company and product. budget is also an imagination. there is not exact representation of the actual situation.
PharmaLedger’s Spotlight Session Presentations at DIA Europe 2021PharmaLedger
Download PharmaLedger’s Spotlight Session presentations from DIA Europe 2021.
In addition to our 3D Virtual Booth that took place all week long at DIA Europe 2021, PharmaLedger hosted two 60-minute Spotlight Sessions.
Spotlight Session #1: PharmaLedger – Demonstrating the Vision of Blockchain Enabled Healthcare
Tuesday, March 16th the sessions kicks off with an introduction of the PharmaLedger project, followed by a look into our Electronic Product Information (ePI) and Anti-Counterfeiting use cases, then concluding with a full demonstration of our first prototype of the PharmaLedger ePI app. Speakers include PharmaLedger Industry Lead Daniel Fritz (Novartis), and ePI use case co-leads Patrick Maher (Novartis) and Ken Thursby (MSD).
Spotlight Session #2: PharmaLedger – Data Privacy and the Vision of a Blockchain Enabled Healthcare
Friday, March 19th following a PharmaLedger introduction, our partners explore how data privacy and blockchain are being used to shape the project and our patient-centric solutions, and look into how PharmaLedger is reshaping the informed consent process for clinical trials with our eConsent use case. Speakers include PharmaLedger Regulatory, Legal & Data Privacy Framework Co-Lead Nenad Georgiev (KU Leuven), eConsent use case co-lead Hernando Giraldo (Boehringer Ingelheim), and Baldwin Mak (Boehringer Ingelheim).
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
www.imi.europa.eu
Disclaimer: Any information on this article solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
IoT Medical Devices | Topic #3 of PharmaLedger's 2nd Open Webinar PharmaLedger
In this IoT Medical Device Use Case presentation, you will find:
An introduction to IoT Medical Device use case presented by : Disa Lee Choun (UCB) and Francesca Rocchi (Bambino Gesù Children Hospital)
The current state and challenges of data collection from medical devices
The advantages of IoT in Clinical Trials
PharmaLedger’s blockchain solution for the future state
Value added by PharmaLedger per actor involved
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
TGA presentation: Codeine Industry Forum - Regulatory options for up-schedulingTGA Australia
To provide sponsors of OTC codeine products with information on how to submit an application to change the class of their product from OTC to prescription medicine
mHealth Israel_Medical Devices in Portugal_Rui Costa_GE HealthcareLevi Shapiro
Presentation about the Medical Device sector in Portugal by Rui Costa, General Manager- Portugal, GE Healthcare, for the mHealth Israel community, June 2, 2020. Includes current trends, sales data, key changes, challenges, reflections, transitions, collaborations, etc
Pharmacovigilance Establishment in India and An overview on PvPImadhvi Chaubey
An overview on Pharmacovigilance Program establishment in India
Including National Pharmacovigilance Program . Objective of the program.
Pharmacovigilance program of India (PvPI)
Achievements of PvPI
The Haemovigilance Program of India
Future challenges of the program
Presentation: Global pharmacovigilance networks - A regulator'sTGA Australia
Global pharmaceutical companies manufacture and distribute a broad portfolio of drug products in multiples regions and countries. The pharmacovigilance system must ensure safety data collection in compliance with local regulations, and consolidate all sources to ensure an ongoing monitoring of potential changes in benefit-risk profiles. It must also guarantee a timely communication to patients, prescribers and regulatory authorities. The complexity resides in the need for a dense network of local safety departments, a strong global organisation processing and analysing cases, and a reporting system ensuring compliance to heterogeneous regulatory requirements. Pfizer has one of the largest pharmacovigilance department among all global companies, and has established patient safety as a core priority. We will describe how pharmacovigilance is organised at Pfizer, global compliance and individual patient safety.
Long term goals and program to achieve the goals. SNOMED CT National Release Center organisation, processes and resources within Socialstyrelsen. Ongoing implementation initiatives.
Lotti Barlow, Socialstyrelsen
SNOMED CT 2019 -seminaari (28.3.2019)
Setting up of new pharmacovigilance centresPriti Gupta
this is just an overview of the setting up of pharamcovigilance with fake name of company and product. budget is also an imagination. there is not exact representation of the actual situation.
PharmaLedger’s Spotlight Session Presentations at DIA Europe 2021PharmaLedger
Download PharmaLedger’s Spotlight Session presentations from DIA Europe 2021.
In addition to our 3D Virtual Booth that took place all week long at DIA Europe 2021, PharmaLedger hosted two 60-minute Spotlight Sessions.
Spotlight Session #1: PharmaLedger – Demonstrating the Vision of Blockchain Enabled Healthcare
Tuesday, March 16th the sessions kicks off with an introduction of the PharmaLedger project, followed by a look into our Electronic Product Information (ePI) and Anti-Counterfeiting use cases, then concluding with a full demonstration of our first prototype of the PharmaLedger ePI app. Speakers include PharmaLedger Industry Lead Daniel Fritz (Novartis), and ePI use case co-leads Patrick Maher (Novartis) and Ken Thursby (MSD).
Spotlight Session #2: PharmaLedger – Data Privacy and the Vision of a Blockchain Enabled Healthcare
Friday, March 19th following a PharmaLedger introduction, our partners explore how data privacy and blockchain are being used to shape the project and our patient-centric solutions, and look into how PharmaLedger is reshaping the informed consent process for clinical trials with our eConsent use case. Speakers include PharmaLedger Regulatory, Legal & Data Privacy Framework Co-Lead Nenad Georgiev (KU Leuven), eConsent use case co-lead Hernando Giraldo (Boehringer Ingelheim), and Baldwin Mak (Boehringer Ingelheim).
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
www.imi.europa.eu
Disclaimer: Any information on this article solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
IoT Medical Devices | Topic #3 of PharmaLedger's 2nd Open Webinar PharmaLedger
In this IoT Medical Device Use Case presentation, you will find:
An introduction to IoT Medical Device use case presented by : Disa Lee Choun (UCB) and Francesca Rocchi (Bambino Gesù Children Hospital)
The current state and challenges of data collection from medical devices
The advantages of IoT in Clinical Trials
PharmaLedger’s blockchain solution for the future state
Value added by PharmaLedger per actor involved
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
TGA presentation: Codeine Industry Forum - Regulatory options for up-schedulingTGA Australia
To provide sponsors of OTC codeine products with information on how to submit an application to change the class of their product from OTC to prescription medicine
mHealth Israel_Medical Devices in Portugal_Rui Costa_GE HealthcareLevi Shapiro
Presentation about the Medical Device sector in Portugal by Rui Costa, General Manager- Portugal, GE Healthcare, for the mHealth Israel community, June 2, 2020. Includes current trends, sales data, key changes, challenges, reflections, transitions, collaborations, etc
Pharmacovigilance Establishment in India and An overview on PvPImadhvi Chaubey
An overview on Pharmacovigilance Program establishment in India
Including National Pharmacovigilance Program . Objective of the program.
Pharmacovigilance program of India (PvPI)
Achievements of PvPI
The Haemovigilance Program of India
Future challenges of the program
Presentation: Global pharmacovigilance networks - A regulator'sTGA Australia
Global pharmaceutical companies manufacture and distribute a broad portfolio of drug products in multiples regions and countries. The pharmacovigilance system must ensure safety data collection in compliance with local regulations, and consolidate all sources to ensure an ongoing monitoring of potential changes in benefit-risk profiles. It must also guarantee a timely communication to patients, prescribers and regulatory authorities. The complexity resides in the need for a dense network of local safety departments, a strong global organisation processing and analysing cases, and a reporting system ensuring compliance to heterogeneous regulatory requirements. Pfizer has one of the largest pharmacovigilance department among all global companies, and has established patient safety as a core priority. We will describe how pharmacovigilance is organised at Pfizer, global compliance and individual patient safety.
Decision Support System for clinical practice created on the basis of the Un...blejyants
The company Socmedica developing an expert system of decision support for medical information systems. The product is aimed at solving the problem of medical errors.
عرض تقديمي دعائي عصري أبيض وأرجواني.pptxOmarAlqadi5
Types of water in pharmaceutical preparation and sources including purified water, distilled water,water for injection, water for irrigation, bacteriostatic water, potable water , drinking water, deionization,pyrogen test
The Conference Board of Canada - Tuesday, April 11, 2017 - Toronto, ON
"Leveraging Change Leadership: Driving Innovation Procurement Forward"
Presentació a càrrec de Antoni Gilabert, director de l'àrea de Farmàcia i del Medicament del CSC
Recent discovered technologies have exposed many new theories and possibilities to improve our standard of living. Medical assistance has been a major research topic in the past, many efforts were put in to simplify the process of following treatment prescriptions. This paper summarizes the work done in developing LoRa driven medical adherence system in order to improve medicine adherence for elderlies. The designed system is composed of two sections; embedded hardware device for the use of patients at home and Web application to manage all patients along with their medicines and keep track of their medicine intake history. LoRa wireless communication technology is used for connecting all embedded devices with a central gateway that manages the network. Hardware and software tests have been conducted and showed great performance in terms of LoRa network range and latency. In short, the proposed system shows promising method of improving medicine adherence.
EMRgecy Medicine: The Impact of EMR/EHR on Healthcare - Keynotes and Expert P...Dr. Susan Dorfman
The event was held in Bedminster, NJ, and was sponsored by ACHE-NJ and Cegedim Dendrite. It brought together experts from around the globe to help attendees better understand practical issues, benefits and challenges of EHR adoption, including interoperability, reimbursement, and more. Dr. Kennedy Ganti, the New Jersey Health IT Commissioner, was a keynote presenter as well as one of the guest panelists.
I have received many emails from people unable to attend this event due to time, date or location who wanted access to this presentation - so here it is!
The keynote presentations and introduction by the panel moderator, Michael Fossel, are presented in this slide deck.
(NOTE: A link to the recorded event - including the infamous panel of experts who received major applause and kudos at the conclusion of the event - will be available soon!)
An eHealth suite for the support of Primary Health Care.
Athena Triantafyllidi, IT Director at IDIKA explains the developments behind the eGov organisation for Social Security and what led them to be considered one of the leading European examples in implementing a digital reference for all those living in Greece.
Twitter: @idikagr
Arnau valls - Sesión técnica UOC Forum CIS
El Hospital Sant Joan de Déu (HSJD) puso en marcha en 2010 la iniciativa “Hospital Líquido (H2.0)” para prestar servicios y ofrecer contenidos a pacientes y familias a través de plataformas digitales: online care, telemedicina, portal del paciente, redes sociales, comunidades online, apps móviles, etc.
En 2015, el HSJD se plantea avanzar para consolidarse como el hospital pediátrico de referencia en la utilización de tecnologías orientadas a proveer servicios directamente a pacientes y familias.
Oscar solans - Sesión técnica UOC Forum CIS
Beneficis pels ciutadans
•Compromís amb la cura de la seva salut, que li permet major autonomia i comoditat
•Prevenció i monitoratge
•Reconeix LMS com a principal font d’informació de salut
•Interacció amb professionals sanitaris a distància
Beneficis pels proveïdors i els professionals de Salut
•Reducció d'errors i proves redundants
•Visió única dels serveis sanitaris
•Permet contacte no presencial
•Compartir informació millora la qualitat dels serveis de salut
Beneficis per l’Administració
•Un ús millor i més eficient dels recursos sanitaris
•La reducció de costos com a conseqüència de la prevenció dels ciutadans i un major compromís en la cura de la seva salut
•Garantia de transparència
•Les tecnologies ajuden a la personalització dels serveis de salut
Joan rodón sesión técnica uoc-forum cis
helsenorge.no:
- Mapeo de los servicios/sistemas ya existentes (nacional, regional, proveedor)
- Ofrecer al ciudadano acceso unificado a información de alta de ingreso, informes de urgencias, diagnósticos, derivaciones, informes de pruebas de laboratorio, radiología, etc.
Ricard bernat - sesión técnica UOC - Forum cis
A propósito de un caso: Área Privada de Paciente.
Demanda continuada por parte del cliente/paciente de acceso a sus datos de salud.
Josep vilalta - sesión técnica uoc forum cis
Interoperabilidad transversal DACS + Blue Button
Capacidad para decidir con quién comparte su información.
Dr Frederic Llordachs - Responsable d’ eHealth
Cada cop hi ha més evidència que facilitant que el ciutadà es responsabilitzi (EMPODERANT) del seu estat de salut i del maneig de la seva salut es milloren els resultats tant des d’un punt de vista social, clínic i econòmic.
Miguel Ángel Mayer - Research Programme on Biomedical Informatics (GRIB) de l’IMIM-UPF: La reutilització de la informació clínica per la recerca biomèdica
El passat 10 de febrer de 2015 va tenir lloc la Jornada: Traslladar l'aportació de valor de les TIC als estats econòmics de les organitzacions sanitàries. Els pressupostos TIC i el reflex econòmic dels intangibles. Presentació de la jornada realitzada per Rafael Lledó, Director general Hospital de Granollers
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
How to Give Better Lectures: Some Tips for Doctors
THE E-HEALTH PANORAMA by Christian FOURY
1. Quitter sommaire préc. suiv.
Créé le :
Par :
Quitter sommaire
THE E-HEALTH PANORAMA
Christian FOURY
Official Representative of
the International Research of
the Mission for European and International Relation and
Cooperation (MREIC) of
the French National Health Insurance Fund (CNAMTS)
2. Quitter sommaire préc. suiv.
Créé le :
Par :
Quitter sommaire
The E-Health Panorama
The Electronic Medical Prescription of Medicines
The Electronic Medical Record and the Shared Electronic
Patient Summary Record
The Software Editors offers either in the Gp’s
practices/healthcare centres and in the hospitals
3. Quitter sommaire préc. suiv.
Créé le :
Par :
Quitter sommaire
The E-Health Panorama
The Electronic Medical Prescription of Medicines (PEM)
Synthesis of the international comparative study
4. Quitter sommaire préc. suiv.
4
Page courante organisme nationalQuitter sommaire préc. suiv.
4
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
The Electronic Medical Prescription of Medicines
The methodology used
1
2
3 The main conclusions
4 The Analysis by Countries
5. Quitter sommaire préc. suiv.
5
The Medical Electronic Prescription of Medicines
5
• In France
The dematerialization project of the Prescription of Medicines has been initiated at the beginning of 2012.
Before the target, foreseen to start in 2014, a functional prototype of Medical Electronic Prescription of
Medicines will be realized in the course of 2013.
The Medical Electronic Prescription of Medicina is an important stake to enhance the efficiency of the
Heathcare system
• Abroad
The dematerialization of the prescription of the Medicines is also an important stake in several European
Countries and already a reality in some of these Countries.
The level of progree of these projects are nevertheless different according to the Countries. Some of them
are in course of deployment and in some others the system is already operational since many years.
Many Countries have also initiated some works but are still in phase of definition of the project
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
6. Quitter sommaire préc. suiv.
6
The Methodology used
6
• Identification of any relevant Foreign Insitutions and or Foreign Experts
An Intenatioal comparative study has been undertaken by the International Research of the Mission for European
and International Relations and Cooperation (MREIC) of the French National Health Insurance Fund to identify
either the Most advanced Countries regarding the Projects of the Electronic Medical Prescription and the
relevant foreign institutions/experts with whom to exchange.
• Note of issue and paper based questionnaire
Paper based questionnaires have been sent to all the Countries identified with some specific questions regarding the
state of progress of the project to the perimeter retained, to the referential used, to the technical environment
of the project…
The feedback from the following countries have already been analyzed : Denmark, Spain (Andalousia), Italy (Emilia-
Romagna), Italy (Lombardy), Great-Britain, Finland, Norway, The Netherlands, Switzerland.
The other answers received will be analysed in a second stage
• Videoconferences/audioconferences
In order to analyse more deeply the answers to our initial questionnaire, some videoconferences, audioconferences
have been organised with the most advanced Countries and having some similarities with the French Context
Project.
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
Denmark • Sweden • Spain (Andalousia) • Italy (Emilia-Romagna) • Italy (Lombardia)
7. Quitter sommaire préc. suiv.
7
The Main Conclusions (1/3)
7
• Main gains expected from the project
For the Doctors : Reliabilisation of the prescription, more simple renewal prescription by incentive the use of
the Help Prescription Softwares. Reduction of the theft of the prescription receipt.
For the Pharmacists : times savings thanks to the automatic data integration, more readable prescriptions…
For the Reimbursement organisms : gains in Work Full Time Staff and this when the invoice process is linked to
the Electronic Medical Prescription.
Improvement of the Fight against the fraud.
For the narcotics prescription : reduction of the misappropriations, traceability either of the prescription and of
the deliveries.
• Points of attention
- Name of the medicines
The medicine codification is not similar in all the Countries. In some countries the GP’s prescribe in using only the
Trade Medicine Name and somewhere else the prescriptions are made in International Common Name.
It does not exist any codified and shared nomenclature for the International Common Name.
- Sizing of the infrastructure
The volume of data is important in all the Countries studied. the Healthcare professionals expectations in terms of
availability and times of answers are strong.
The technical dysfunctioning are the majorn risk of the project. An inadequate infrastructure and or under sized
including at the beginning of the project could put in danger the use of the system.
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
8. Quitter sommaire préc. suiv.
8
The main conclusions (2/3)
8
• Proposal of evolution
- For the Doctor :
Access to all the Electronic Medical Prescriptions of the patient : this would allow to fight against
the therapeutic redundancy.
Visual display of the deliveries made on its Electronic Medical Precriptions : Thus, the Doctor could
ensure that the patient has well withdrawn the prescribed medicines instead of being able to
ensure that he takes correctly his treatment.
- For the Pharmacist :
Access for the Pharmacist to all the prescriptions of the patient : This allow to make sure that
there is no risk of incompatibility and or adverse effect between several treatments in process for
the patient.
Possibility for the Pharmacist to suspend an Electronic Medical Prescription : In case of risk for the
patient, after advise of the GP, the pharmacist can suspend the Electronic Medical Prescription.
.
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
9. Quitter sommaire préc. suiv.
9
The main conclusions (3/3)
- For the patient :
Identification of the patient : Many functionnalities can not be offered if the patient is
not identifiable in a unique way with a high level of security and condidentiality for the
access of the medical data.
Today and regarding the French Situation : Our Social Security Card is not personal due to
the fact that it contains also the data of the beneficiaries. The Number of Registration in
the Directory called NIR is predictible and does not offer a high level of security and
confidentiality.
A web interface allow a patient to access to its Electronic Medical Prescriptions. Different
functionalities are proposed according toe the Countries studied. A single account by
patient is essential to guarantee the confidentiality of the Electronic Medical
Prescriptions.
10. Quitter sommaire préc. suiv.
10
Analysis by Countries
10
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
• Key figures
France Denmark Sweden
Spain
(Andalousia)
Italy (Emilia-
Romagna)
Italy
(Lombardia)
Population
(in millions
of
inhabitants)
65 6 10 8 4 10
Medicines
expenditure
s
(in euros by
year and
per capita)
437 219 277 218 NC NC
Number of
prescription
s
(in millions
by year)
Env.
600
Env. 25 36 180 70 140
Number of
Doctors
120
000
20 500 38 000 NC 4000 NC
Number of
Pharmacists
22 000 250 900 3600 NC NC
11. Quitter sommaire préc. suiv.
11
Analysis by Countries
11
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
Denmark
• Decentralized Healthcare system.
• Decentralized reimbursement system
• Project started in the 1990’s
• Up to 2007, around 97% of the prescriptions was sent and exchanged
electronically that it to say around 25 millions of prescriptions by year.
Gains of the project :
• For the Doctors : Reliabilisation of the prescription due to the use of an informatic module allowing to
detec any medicines interactions.
• For the Pharmacists : times savings by avoiding to enter again the data and reduction of the calls to the
prescriber in order to obtain any confirmation regarding the elements contained on the prescriptions
Difficulties met :
• Initial process insufficiently flexible : the patients should choose the pharmacy during the consultation.
This system has been reviewed to answer to the patient expectations. Today the system looks like to this
one we would like to implement and to generalize in France.
• Under sizing of the infrastructure : Problems of availability have been occured at the beginning of the
deployment of the project which has delayed anc complicated the build up process of the project.
Elements of reflection :
• Important penetration of the system, due to an important « accompanying measures ».
• The patient has an important role in the process. He controls the access of its Electronic Medical
Prescriptions.
12. Quitter sommaire préc. suiv.
12
Analysis by Country
12
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
Sweden
• Decentralized Healthcare System.
• Centralized Reimbursement System.
• Projet started in the 1990’s
• In 2010, 80% of the prescriptions (that means 2,6 millions by month)
have been electronically sent and exchanged.
Gains of the project :
• For the Doctors : Decrease of the insecurity linked to the drug addicts, The theft of the secure medical
receipt have totally disappeared.
• For the Pharmacists : times savings by avoiding to enter again the data and reduction of the calls to the
prescriber in order to obtain any confirmation regarding the elements contained on the prescriptions
• For the patients : possibility to go to any pharmacy with only an Identity Document for the delivery of the
medicines which has increased the flexibility of the process.
• Reliabilisation of the prescriptions : The Electronic Medical Prescription has allowed an enhancement of
the quality of the prescriptions (reduction of 10% of the prescriptions which should be reviewed by the
pharmacist) thanks to the use of the referentials and a more readable writing.
Difficulties met :
• Insufficient gains for the prescribers : the prescribers find that the Electronic Medical Prescription does
not improve their medical practices. They blame the absence of visibility on the Electronic Medical
Prescription of the patient and the deliveries made on their Electronic Medical Prescriptions.
• Technical environment : The Electronic Medical Prescription has been taking place in an informatic
environment containing several bricks of Information System not coherent according to the Counties.
Problems of compatibiliy between the systems have delayed the deployment in several County Counties.
13. Quitter sommaire préc. suiv.
13
Analysis by Country
13
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
Spain (Andalousia)
• Healthcare system is managed by the Autonomous Community, the
doctors are salaried of the Andalousian Public Healthcare System.
• Centralized Reimbursement system.
• Project started in the 2000.
• In 2011, 71% of the prescriptions (that means 127 millions par an) are
electronically exchanged.
Gains of the project :
The project Receta XXI has been realized with the European funding. An evaluation of the benefits brought
by the project has been performed by the European Commission (Study EHRimpact).
12 years after the launch of the first works, the analyse cost-advantage show a net cost benefit ratio of 1.12.
In 2006, 3 years after the beginning of the implementation of Receta XXI, the earnings exceed the costs.
Notably thanks to the reduction of the consultations of the patients having a chronic diseases, the reduction
in the use of the paper, the increase of the generic prescriptions and the improvement of the quality
prescriptions.
Difficulties met :
• Lack of flexibility for the patient : the delivery of the medicines is only possible if the patient have with
him its Social Security Card. The patients wish to have a dispensation system based only on an identity
control.
• Realization of a medicine nomenclature : A codification table of medicines in Common Name has been
realized in Andalousia and adopted later by the other Autonomous Communities. The doctors can
prescribe among a list of 12 000 medicines (in trade name) and 3 000 active ingredients. In Andalousia,
around 92% of the Electronic Medical Prescriptions are drawn up in active ingredients.
14. Quitter sommaire préc. suiv.
14
Analysis by Country
14
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
Italy
(Emilia-Romagna)
• Healthcare System managed by the Region.
• Reimbursement System in course of centralization.
• Project initiated in 2006, prototype foreseen for the end of 2012 and
target solution in 2014.
Gains of the project :
•The project is in progress, No one benefits evaluation study has been undertaken at this date.
Difficulties met :
•Under Healthcare Professionals informatics equipment : The acquisition cost and or the renewal of the
informatic equipment park can not be only supported by the Healthcare professionals.
•The High number of softwares which has been modified in order to allow the emission of the prescription
has got some consequences in terms of costs and time schedule.
Elements of reflection :
•Two documents form the prescription : an order form destinate to the pharmacist containing the medicines
to deliver (notably the number of packages) and a patient instructions for use in order to know how to take
the prescribed medicines. The instructions for use is not sent electronically.
15. Quitter sommaire préc. suiv.
15
Analysis by Country
15
Synthèse de l’étude internationale
CNAMTS/Programme 2
Prescription électronique de médicaments
Italy (Lombardia)
• Decentralized Healthcare System.
• Reimbursement system in course of centralisation.
• Project initiated in the 1990’s on a restrictive perimater (not delivery
possible).
• In 2011, 86,5 millions of Electronic Medical Prescriptions have been
sent and exchanged from the doctors to the pharmacists.
Gains of the project :
• The project is in progress, no one evaluation benefits study has been undertaken at this date .
Difficulties met :
• The high number of softwares which has been modified to allow the emission of the prescription has got
some consequences in terms of costs and time schedule.
• The project is introduced by legislation, any healthcare professionals accompanying measures are
foreseen. The Healthcare Professionals adhesion is the main risk of the project.
Elements of reflection :
• Two documents form the prescription : an order form destinate to the pharmacist containing the
medicines to deliver (notably the number of packages) and a patient instructions for use in order to
know how to take the prescribed medicines. The instructions for use is not sent electronically.
16. Quitter sommaire préc. suiv.
16
The E-Health Panorama
The Electronic Medical Record and the Shared Electronic
Patient Summary Record
Synthesis of the international comparative study
17. Quitter sommaire préc. suiv.
17
The Electronic Medical Record
The Electronic Medical Record
The main conclusions
1
2
3 The analysis by Countries
18. Quitter sommaire préc. suiv.
18
The Electronic Medical Record
● In France
In France, the initiative was officially launched at national level in 2004 in
the context of the law introduced by Health Minister Philippe Douste-
Blazy bearing on reform of the Social Security system. Major return on
investment was expected, but today it must be said that a good deal
more reserve is called for, with focus first of all on development of uses.
● Abroad
Electronic Health Records have been in use in a variety of forms in many
countries for several years now
19. Quitter sommaire préc. suiv.
19
The Main Conclusions (1/2)
● First step :
We need to work closely an directly with the Healthcare Professionals and notably with
the Gp’s in order to help them to buy a computer and to use any compatible
Professional EMR Softwares – PROFESSIONAL EMR SOFTWARES
● Second step :
We need to work closely and directly with the Healthcare Professionals and notably with
the Gp’s in order to identify all the documents that they would accept to share with the
other Healthcare Professionals and Hospital Establishments and this in the framework
of the Shared Medical Electronic Patient Summary Record – SHARED MEDICAL
ELECTRONIC PATIENT SUMMARY RECORD
20. Quitter sommaire préc. suiv.
20
The Main Conclusions (2/2)
● Third step :
We should determine in the framework of the Shared Electronic Patient Summary Record
which categories of documents the most important put at the disposal of each patient
and this through a dedicated secure internet portal. ACCESS FOR THE PATIENT TO ITS
EMR THROUGH A SECURE INTERNET PORTAL
● Fourth step :
● Regarding the EMR of the chronic diseases patients and in the framework of the Global
Healhcare Pathway we should provide all the information needed by all the Healthcare
Professionals concerned. FOR CHRONIC DISEASES PATIENTS PROVIDE TO ALL THE
HEALTHCARE PROFESSIONNALS CONCERNED ALL THE DOCUMENTS NEEDED IN ORDER
TO OFFER A COMPREHENSIVE ANSWER TO ALL THEIR HEALTHCARE PROBLEMS
21. Quitter sommaire préc. suiv.
21
Analysis by Country
● Germany
- The Electronic Medical Record does not exist at the Federal/National Level at this date.
Nevertheless, it exists some pilot projects at the Lander Level which have not for aim to implement
a unique solution at the Federal/National Level
- In the Primary Care Sector the GP’s use a Professional Electronic Medical Record to register either
administrative and clinical data. These Electronic Medical Records are under the control of the GP’s
themselves
- In the hospital Care Sector the Information System are used to register the similar data at those
registered in the primary care sector. The Hospital Information System are also under the control
of the Healthcare professionals.
The data and categories of documents contained in the Electronic Medical Record vary according to
the Software editors.
22. Quitter sommaire préc. suiv.
22
Germany
● Germany (to continue)
According to a recent publication from a multidisciplinary working group, the Electronic Medical Record should contain :
• A certain number of clinical documentation on the healthcare events :
- Medical measures,
- Symptoms,
- Diagnostics,
- Therapeutic objectives
• A special documentation :
- Laboratory test results,
- Documentation on the medications.
• A certain number of complementay documents :
- Documents provided by the other medical specialists
• Virtual views :
- Set of data from the Emergency Care,
- Basic clinical information
- Source : ZTG Zentrum fûr Telematik und Gesundheitswesen GMbh : Electronische Akten im Gesundheitswesen –
Ergebnisse des bundesweiten Arbeitskreises EPA/EFA, 2011.
23. Quitter sommaire préc. suiv.
23
Germany
● Germany (to continue and end)
- The prior objective before the implementation of the Electronic Medical
Record is to deliver to all the patients insured by The German Health Insurance
Funds an Electronic Healthcare Card (70 %) in the framework of the basic
deployment which should have been started at the end of 2012
- The Electronic Medical Record should be available at the Federal/National Level
up to 2019
24. Quitter sommaire préc. suiv.
24
Austria
● Austria
- The Austria is currently working on the implementation of an Electronic Medical Record which
should be generalized in 2016.
- In the Primary Care Sector the GP’s use a Professional Electronic Medical Record to register either
administrative and clinical data. These Electronic Medical Records are under the control of the GP’s
themselves
- In the hospital Care Sector the Information System are used to register the similar data at those
registered in the primary care sector. The Hospital Information System are also under the control
of the Healthcare professionals.
- A certain number of patient data and documents should be available to these one (first step) :
*Discharge letters delivered by the hospitals,
* Laboratory test results,
* Hospital, Gp’s and Pharmacies prescriptions,
*Medical and or Clinical register.
25. Quitter sommaire préc. suiv.
25
Austria
● Austria
It is also foreseen in a second step of the deployment of the Electronic Medical Record to
to have a Shared Medical Electronic Patient Summary Record.
In the first sept of the development of the Electronic Medical Record, the patients are not
authorized to register their own documents and or to put them available.
The informatic equipment being different from a doctor to another one the necessity to
fund partly the modernization of the equipment has been recognized by the Austrian
Authorities.
26. Quitter sommaire préc. suiv.
26
Belgium
● Belgium
- The Electronic Medical Record should be seen here as a Shared Electronic Patient Summary Record
which should contribute to the enhancement of the healthcare quality and safety
- The Belgium authorities will is to allow thanks to the implementation and the real use of the
Professionals Electronic Medical Records the access of the data in a Shared way :
* Contained in the Professional EMR software of the Healthcare professionals-Gp’s,
* Contained in the hospital establishments servers.
- It is important to notice that at this date the EMR is not yet available.
- Existence of the E-Health box tool, which is a secure electronic mailboxes offer for free at all the
healthcare professionals includind the hospital establishments. This allow at the hospitals for
example to send for free the discharge letters (encrypted) to the Gp’s.
27. Quitter sommaire préc. suiv.
27
Belgium
● Belgium (To continue) :
- It is foreseen to open the Shared Medical Electronic Patient Summary Record to the
patients/citizens.
- To allow the Belgium Healthcare professionals to buy an EMR Software the Belgium Authority have
decided to delivrer a grant of 850 euros by professional (Gp’s, Nurses and Physiotherapists).
- The process of labelisation/credentialing process enhance the quality of the softwares but does
not incentive the real use of these ones by the Healthcare professionals mentioned above.
Taking into account this fact, the belgium authorities have decided to measure the good use of the
EMR Software by the Healthcare Professionals concerned and to ensure if these one have an EMR
Software and if they use them really.
28. Quitter sommaire préc. suiv.
28
Belgium
● Belgium (To continue)
The Belgium authorities have therefore decided to help to the development and
to the concrete use of the Professionals EMR :
- By allocating a lump sum payment of 80 euros by year and by doctor for the
management of the Professional EMR and this in the interest of the patient,
- To incentive financially the patients to have a referent Gp’s in charge of
managing his EMR by reducing the outpocket co-payment for each patient.
29. Quitter sommaire préc. suiv.
29
Belgium
● Belgium (To continue)
- According to the Belgium Authorities the Hospital Informatisation System is not
performant in the sense they produce only summary of hospitalization documents and
the consultation of the clinical biological test results. These documents being then
storage in a result server.
To address this problem the Belgium Authorities allocate each year and by hospital the
amount of 12 000 euros.
- The Belgium authorities are in favour of gathering all the regional existing results servers
in one server in which we will find the all the relevant documents concerning a patient.
The GP’s could connect him thus at this regional network wich would allow at this one
to access to a list of documents for a patient and if there are several regional servers to
collect all the documents known in these ones for a patient.
30. Quitter sommaire préc. suiv.
30
Belgium
● Belgium (To continue)
-In the Dutch Community, there are 4 regional results servers,
- In Brussels capital there is 1 regional result server,
- In the French Community, there is 1 regional result server.
The French Community for example offer to their hospitals to be interconnected with a
unique results regional server to allow the Gps and the other Healthcare professionals
to access to any relevant documents for any patient.
31. Quitter sommaire préc. suiv.
31
Spain
● Spain
The Electronic Medical Record is still not available at the National Level
They are many initiatives undertaken by each Autonomous Community
Example : The Autonomous Community of the Catalogna
- A Professional EMR is used by almost all the Healthcare professionals and the Hospitals (88 %) :
* 7,9 Millions of Professional EMR existing including 40 M of clinical documents - the Catalogna have
7,5 Millions of inhabitants,
* 50 500 Healthcare Professionals access to these Professional EMR through a dedicated Professional
Portal : In 2012 there are been 1,74 Billions of consultations.
- All the Medical Imaging are stored in a Regional PACS Server,
- The Electronic Medical Prescription is already operational between the prescribers and the
pharmacists. This project is deployed since 2008.
32. Quitter sommaire préc. suiv.
32
Spain
● Spain (To continue)
- Each citizen/each patient can consult some of their medical
informations on a dedicated and secure Internet Portal. A version for
smartphone is in progress in the framework of a pilot test.
- It is foreseen to have an Shared Medical Electronic Patient Summary
Record as it exist in the Autonomous Community of Catalunya at the
National Level.
33. Quitter sommaire préc. suiv.
33
Italy
● Italy – National Level and Emilia-Romagna Region
In Italy the Healthcare System is managed by each Region and
consequently the EMR is therefore build up with each Italian Regions
hereby certify by the EMR study within the Emilia-Romagna Region
It does not have an EMR at the National Level. Nevertheless there are the
will of the Italian Public Authorities to have at the National Level a
Shared Medical Electronic Patient Summary Record called « Fascicolo
Sanitarie Elettronico ».
34. Quitter sommaire préc. suiv.
34
Italy
● Italy – Emilia-Romagna Region
- In the Primary Care Sector and concerning the GP’s, there are 16 Professionals EMR Softwares. On
this subject, the Emilia Romagna Region is currently in the way to proceed to a call for tender in
order to retain only and at the end of the process a unique EMR Software editors.
- In the Hospital Care Sector we find too the existence of compatible Professionals EMR Softwares.
- All the Healthcare Professionals of the Italian Emilia-Romagna Region are computerized and this
thanks to :
* First the creation of a regional server called « SOLE-SANITA ON LINE – HEALTH ON LINE »
implemented since 2003 and up to 2005 among which the main objective was to build up a
informatized network in the framework of the individual clinical pathway of the patient and to
share all the relevant clinical documents contained in the Professional EMR of the GP’s, Paediatrists
with all the Healthcare Structures of the Emilia-Romagna Region.
35. Quitter sommaire préc. suiv.
35
Italy
● Italy – Emilia-Romagna Region
- And secondly through the financial participation of the Healthcare Regional Directorate :
• in the Gp’s and Healthcare Professionals training,
• Cost of the 16 Professionals EMR maintenances,
• The cost of connexion of the GP’s computer,
• The Online Help Desk Service for the Gp’s, the Healthcare Professionals and the citizens,
• The purchase of the informatic material (Personal Computer and Printers) for the GP’s
36. Quitter sommaire préc. suiv.
36
Italy
● The Shared Medical Electronic Patient Summary Record is managed by the Italian Minister of
Health at the National Level and by each Italian Region at the Local Level – Example of the
management of this project by the Emilia-Romagna Region :
- The Facicolo Sanitarie Elettronico FSE– Shared Medical Electronic Patient Summary Record is a
Secure Internet Portal containing all the data of the patient which has been developed within the
Emilia-Romagna Region from 2008 to 2010. There have been an experimentation stage launched in
2011 and a generalization stage since 2012.
- The Healthcahre Professionals who have the responsibility of the healthcare of their patients in the
Public Structures can access to the FSE.
- The Healthcare Professionals should send any relevant clinical documents in the FSE and this by the
intermediate of the corporate software user integrated to the Sole Infrastructure.
37. Quitter sommaire préc. suiv.
37
Italy
● Shared Electronic Patient Summary Record managed by the Italian Minister of Health at
the National Level and by each Italian Region at the Local Level – Example of the
management of this project by the Emilia-Romagna Region ( to continue) :
- The Gp’s through their own Professionals EMR can see all the referral documents produce by
the Public Structure, the Specialists Pharmaceutical Prescriptions and send the « Patient
Summary » of the Patient with the information of their own Professionals EMR Sofwares.
- The patient have an access to his FSE and he is free to add any paper documents by scan.
- At the 31st of December 2012, there have been :
• Created 13 500 actives FSE,
• Stored in the Regional Data Server around 19 millions of clinical documents and around 33
millions of specialists pharmaceutical prescriptions,
• Consulted by the patients : 63.500 clinical documents and prescriptions.
38. Quitter sommaire préc. suiv.
38
Switzerland
● Switzerland
In Switzerland, the Healhcare System is managed par each County called
the Swiss Cantons. The EMR is therefore build up at a Local Level
It does not have an EMR at the Federal Level. Nevertheless there are the
will of the Swiss Public Authorities to have at the Federal Level a Shared
Medical Electronic Patient Summary Record.
39. Quitter sommaire préc. suiv.
39
Switzerland
● The EMR managed by the Geneva Canton
- A Shared Medical Patient Summary Record exist as one of the pilot project in Switzerland. It is
called « E-Toile Project ».
- In Switzerland around 20 % of the doctors have and use a compatible Professionals EMR Software
and it is the situation in the Geneva Canton too.
- The originality of the E-Toile Project is that E-Toile does not store any information but allow (or
not) the access for any request of all the databases of all the stakeholders involved in this project
(clinics, radiologists, pharmacists, hospitals, doctors, etc).
The partners themselves keep the control on their own data and decide which informations of their
Professionals EMR software they wish to put eventually at the disposal of E-Toile.
40. Quitter sommaire préc. suiv.
40
Switzerland
● The EMR managed by the Geneva Canton
E-Toile store only any pdf documents at this stage, at the exception of the medication informations
which are codified (possibility to exchange information).
The project E-Toile is in a pilot project stage within a Region of 50 000 inhabitants in the Medical
Center of the Onex Medical Group.
The Onex Medical Group is composed of 80 Gp’s who share at this date 280.000 Professionals EMR.
These Professionals EMR contains : a synthesis, the medicines, the radiologies imaging, the
laboratories results, the letters, the medical reports, the medical certificates for the population of
the Onex Region.
41. Quitter sommaire préc. suiv.
41
Switzerland
● The future Shared Medical Electronic Patient Summary Record
by the Ministry of Health at the Federal Level and among which
the example could be the Pilot Project of the Shared Medical
Electronic Patient Summary Record fom the Geneva Canton
- The main objective of the E-Health Swiss Strategy is to encourage all the Swiss Cantons to
implement an EMR and to have a Shared Medical Electronic Patient Summary Record if it is
possible in 2015.
- The pilot projects of an EMR in the Swiss Cantons are : Canton of Geneva (E-Toile), Canton of Basel-
Stadt, Canton of Wallis.
- It has not been yet defined at this stage the kind of documents we will find in the future Shared
Medical Electronic Patient Summary at the Federal Level. The discussions around this issue will
start in 2013. We think if we refer to the pilot projects of the Swiss Cantons that we will find the
following documents : Medical Reports, laboratories tests, the e-prescription, the e-medication, the
results.
42. Quitter sommaire préc. suiv.
42
The E-Health Panorama
The Software Editors Offers either in the Gp’s
practises/Healthcare Centres and in the Hospitals
Synthesis of the international comparative study
43. Quitter sommaire préc. suiv.
43
Software editors offers of the Gp’s practices
● The Results obtained show us a first classification in two categories of practices, that is
to say :
- For the Software Editors offers of the Gp’s practices/Healthcare Centres :
- In one side, the Countries and or Regions, County Councils, Autonomous Communities
ensuring themselves the healthcare dispensation : have a few number of house
software developed internally and sometimes a unique one from a call for tender
process :
• Canada (Alberta),
• Spain (Catalogna),
• Scotland,
• United States (HMO Intermountain Healthcare and Kaiser Permanente),
• Italy (Emilia-Romagna),
• Sweden.
44. Quitter sommaire préc. suiv.
44
Software editors offers of the Gp’s practices
• In an other side and similar to France, some Countries are leaving the free market and
ensure nevertheless an homologation/labelisation/certification process of the
softwares used :
*Austria,
*Belgium,
* United States (Federal Level),
* The Netherlands,
* Switzerland among which the Geneva Canton.
45. Quitter sommaire préc. suiv.
45
Software editors offers in the hospitals
- For the Hospital Care Sector, the situations met in the other foreign Countries are
relatively and or quite similar to what we meet in France :
• A small editors number cover the major part of the market,
• Even if they do not cover all the needs from an hospital,
• This conduct the hospital to launch a call for tender to many editors and softwares,
• We find either some public offers and or Hospital Establishment Owners (again this
practice is less developed in France) and some national and international private offers,
• To notice in some Countries a quicker start offer with external storage share the
Information System of several hospitals : type Saas and or Cloud
We do think that the Ambulatory/Hospital communication is everywhere at its beginning –
except in any Integrated Healthcare System (USA Intermountain Healthcare, Kaiser
Permanente, Spain Autonomous Community of Catalogna).
47. Quitter sommaire préc. suiv.
47
Professionnal contact details
Christian FOURY
Official Representative of
The International Research of
The Mission of the European and International Relations and Cooperation
(MREIC) of
The French National Healh Insurance Fund (CNAMTS)
CPAM de la Sarthe
178 Avenue Bollée
72 033 Le Mans Cedex 9
Telephone : + 33 2 43 50 74 89
Mobile : + 33 6 60 49 58 87
E-mail : christian.foury@cpam-lemans.cnamts.fr